Cell cycle inhibition and retinoblastoma protein overexpression prevent Purkinje cell death in organotypic slice cultures.
Purkinje cells are vulnerable to a number of physical, chemical, and genetic insults during development and maturity. Normal development of these cells depends on the cell-cell interactions between granule and astroglial cell populations. Apoptotic death in Purkinje neurons had been shown to be associated with cell cycle activation, and new DNA synthesis is associated with Purkinje cell death in staggerer and lurcher mutant mice. Here using an in vitro organotypic slice culture model from 9 (P9) and 4 days (P4) old postnatal rats we show that the cyclin dependent kinase (cdk) inhibitors (roscovitine, olomoucine, and flavopiridol) protect the Purkinje cells from cell death. The results are more pronounced in the cerebellar sections from P4 rats. Analysis of Purkinje neurons in sections from P4 rats after 1 week of culturing showed that while there were very limited calbindin positive neurons in the untreated sections the cdk inhibitor treated sections had a notably higher number. Although treatment with cdk inhibitors inhibited Purkinje cell loss significantly, the morphology of these neurons was abnormal, with stunted dendrites and axons. Since the retinoblastoma protein (Rb) is the major pocket protein involved in determining the differentiated state of neurons we examined the effect of over-expressing Rb in the organotypic cultures. Rb overexpression significantly inhibited the Purkinje cell death and these neurons maintained their normal morphology. Thus our studies show that the cell death in Purkinje neurons observed in organotypic cultures is cell cycle dependent and the optimal survival requires Rb.
Padmanabhan
Jaya
J
Department of Pathology, Taub Center for the Study of Alzheimer's Disease and Aging Brain, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA. 10032
Brown
Kristy
K
Shelanski
Michael L
ML
D000818:Animals; D002453:Cell Cycle / Q000502:physiology*; D016923:Cell Death / Q000502:physiology*; D018844:Cyclin-Dependent Kinases / Q000037:antagonists & inhibitors; D004791:Enzyme Inhibitors / Q000494:pharmacology; D007150:Immunohistochemistry; D009924:Organ Culture Techniques; D011689:Purkinje Cells / Q000166:cytology* / Q000378:metabolism* / Q000473:pathology; D051381:Rats; D016160:Retinoblastoma Protein / Q000096:biosynthesis*
D004791:Enzyme Inhibitors; D016160:Retinoblastoma Protein; D018844:Cyclin-Dependent Kinases